UY29802A1 - Análogos de la feniletilamina y su uso en el tratamiento del glaucoma - Google Patents
Análogos de la feniletilamina y su uso en el tratamiento del glaucomaInfo
- Publication number
- UY29802A1 UY29802A1 UY29802A UY29802A UY29802A1 UY 29802 A1 UY29802 A1 UY 29802A1 UY 29802 A UY29802 A UY 29802A UY 29802 A UY29802 A UY 29802A UY 29802 A1 UY29802 A1 UY 29802A1
- Authority
- UY
- Uruguay
- Prior art keywords
- phenylethylamine
- glaucoma
- treatment
- analogs
- eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describen análogos de la feniletilamina útiles para el tratamiento de enfermedades oftálmicas como el glaucoma y la presión ocular. Los compuestos son generalmente formulados como composiciones farmacéuticas para su administración tópica en el ojo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72024805P | 2005-09-23 | 2005-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29802A1 true UY29802A1 (es) | 2007-02-28 |
Family
ID=37527034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29802A UY29802A1 (es) | 2005-09-23 | 2006-09-19 | Análogos de la feniletilamina y su uso en el tratamiento del glaucoma |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070072920A1 (es) |
AR (1) | AR058055A1 (es) |
TW (1) | TW200744567A (es) |
UY (1) | UY29802A1 (es) |
WO (1) | WO2007038372A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005053688A1 (en) * | 2003-11-26 | 2005-06-16 | Alcon, Inc. | Substituted furo[2,3-g] indazoles for the treatment of glaucoma |
WO2007149728A2 (en) * | 2006-06-20 | 2007-12-27 | Alcon Research, Ltd. | Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
US7982071B2 (en) | 2007-10-05 | 2011-07-19 | Acucela Inc. | Alkoxy compounds for disease treatment |
US8076516B2 (en) | 2007-11-01 | 2011-12-13 | Acucela, Inc. | Amine derivative compounds for treating ophthalmic diseases and disorders |
CN102203058B (zh) * | 2008-09-05 | 2014-11-12 | 奥克塞拉有限公司 | 用于治疗眼科疾病和紊乱的连接有硫的化合物 |
EP2448569B1 (en) | 2009-07-02 | 2021-10-27 | Acucela, Inc. | Pharmacology of visual cycle modulators |
JP2015505536A (ja) | 2012-01-20 | 2015-02-23 | アクセラ インク. | 疾患の処置のための置換された複素環化合物 |
CN102993032B (zh) * | 2012-12-20 | 2014-08-27 | 山东阿如拉药物研究开发有限公司 | 一种盐酸甲氧明的合成方法 |
CA2998673C (en) * | 2015-09-23 | 2023-12-12 | Aerpio Therapeutics, Inc. | Methods of treating intraocular pressure with activators of tie-2 |
CN109369353A (zh) * | 2018-11-28 | 2019-02-22 | 嘉实(湖南)医药科技有限公司 | 一种美托洛尔中间体的制备方法 |
BR112023018237A2 (pt) * | 2021-03-12 | 2023-11-28 | Gilgamesh Pharmaceuticals Inc | Fenalquilaminas e métodos para fabricação e uso das mesmas |
WO2023205116A1 (en) * | 2022-04-19 | 2023-10-26 | Gilgamesh Pharmaceuticals, Inc. | Pyridine derivatives for treating psychiatric disorders |
WO2024059090A1 (en) * | 2022-09-12 | 2024-03-21 | Gilgamesh Pharmaceuticals, Inc. | Phenalkylamines and methods of making and using the same |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US664286A (en) * | 1899-08-19 | 1900-12-18 | Waterbury Mfg Company | Foot-pump for bicycles. |
US4105695A (en) * | 1975-12-11 | 1978-08-08 | Bristol-Myers Company | 2-Amino-1-(2,5-dimethoxyphenyl)-butanes |
FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
US5151444B1 (en) * | 1987-09-18 | 1999-07-06 | R Tech Ueno Ltd | Ocular hypotensive agents |
US5011846A (en) * | 1988-02-23 | 1991-04-30 | Merrell Dow Pharmaceuticals Inc. | Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
EP1224935A3 (en) * | 1988-09-06 | 2003-03-26 | Pharmacia Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
WO1993000333A1 (en) * | 1991-06-21 | 1993-01-07 | Smithkline Beecham Plc | Tryptamine analogues, their synthesis and their use as 5-ht1-like or 5-ht2 receptor agonists |
GB9216380D0 (en) * | 1992-07-31 | 1992-09-16 | Glaxo Group Ltd | Medicaments |
US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5290781A (en) * | 1993-01-05 | 1994-03-01 | Iolab Corporation | Ketaneserinol as an agent to reduce intraocular pressure |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
TW270114B (es) * | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
TW334423B (en) * | 1993-10-22 | 1998-06-21 | Hoffmann La Roche | Tricyclic 1-aminoethylpyrrole-derivatives |
US5538974A (en) * | 1994-01-27 | 1996-07-23 | Senju Pharamceutical Co., Ltd. | Ophthalmic composition for lowering intraocular pressure |
ATE166227T1 (de) * | 1994-03-18 | 1998-06-15 | Senju Pharma Co | Sarpogrelat enthaltende opthalmologische zubereitungen zur senkung des intraokularen druckes |
TW403738B (en) * | 1994-08-12 | 2000-09-01 | Hoffmann La Roche | Tricyclic pyrazole derivatives |
US5874477A (en) * | 1994-08-12 | 1999-02-23 | The University Of Hawaii | Method of treatment for malaria utilizing serotonin receptor ligands |
US5902815A (en) * | 1996-09-03 | 1999-05-11 | Washington University | Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction |
CA2325559A1 (en) * | 1998-04-14 | 1999-10-21 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
US6960579B1 (en) * | 1998-05-19 | 2005-11-01 | Alcon Manufacturing, Ltd. | Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders |
EP1112106B1 (en) * | 1998-09-18 | 2005-11-23 | Alcon Manufacturing Ltd. | Serotonergic 5ht2 agonists for treating glaucoma |
US20030207890A1 (en) * | 2001-02-23 | 2003-11-06 | Collier Robert J | Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
US6806285B1 (en) * | 2000-03-17 | 2004-10-19 | Alcon, Inc. | 5-Hydroxyl indole derivatives for treating glaucoma |
US7012090B1 (en) * | 2000-03-17 | 2006-03-14 | Alcon, Inc. | Pyranoindoles for treating glaucoma |
US7005443B1 (en) * | 2000-03-17 | 2006-02-28 | Alcon, Inc. | 5-Hydroxy indazole derivatives for treating glaucoma |
WO2001070705A1 (en) * | 2000-03-17 | 2001-09-27 | Alcon, Inc. | 2-acylaminobenzimidazole derivatives for treating glaucoma |
US6956036B1 (en) * | 2000-03-17 | 2005-10-18 | Alcon, Inc. | 6-hydroxy-indazole derivatives for treating glaucoma |
US6927233B1 (en) * | 2000-03-17 | 2005-08-09 | Alcon, Inc. | 5ht2 agonists for controlling IOP and treating glaucoma |
US6998489B2 (en) * | 2001-06-01 | 2006-02-14 | Alcon, Inc. | Methods of making indazoles |
CA2447479A1 (en) * | 2001-06-01 | 2002-12-12 | Alcon, Inc. | Novel arylaminopropane analogues and their use for the treatment of glaucoma |
JP2004532887A (ja) * | 2001-06-01 | 2004-10-28 | アルコン,インコーポレイテッド | 新規な融合インダゾールおよびインドールおよび緑内障治療へのこれらの使用 |
DK1392292T3 (da) * | 2001-06-01 | 2006-05-29 | Alcon Inc | Pyranoindazoler og deres anvendelse til behandling af glaukom |
US6884816B2 (en) * | 2001-08-31 | 2005-04-26 | Alcon, Inc. | Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma |
AU2002346671B2 (en) * | 2001-12-14 | 2005-08-11 | Alcon, Inc. | Aminoalkyl-benzofuran-5-OL compounds for the treatment of glaucoma |
TW593302B (en) * | 2001-12-20 | 2004-06-21 | Alcon Inc | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
MXPA05002259A (es) * | 2002-08-30 | 2005-07-05 | Alcon Inc | Compuestos de 5-croman-5-il-etilamina sustituidos y uso para el tratamiento de glaucoma. |
EP1558238A4 (en) * | 2002-09-24 | 2006-08-30 | Univ Virginia Commonwealth | BETA-HYDROXYPHENYL ALDYLAMINE AND ITS USE FOR THE TREATMENT OF GLAUCOMA |
AU2003300915B2 (en) * | 2002-12-13 | 2008-08-28 | Alcon, Inc. | Novel benzopyran analogs and their use for the treatment of glaucoma |
CN100361977C (zh) * | 2002-12-23 | 2008-01-16 | 爱尔康公司 | 1-烷基-3-氨基吲唑 |
WO2005053688A1 (en) * | 2003-11-26 | 2005-06-16 | Alcon, Inc. | Substituted furo[2,3-g] indazoles for the treatment of glaucoma |
US7338972B1 (en) * | 2003-12-15 | 2008-03-04 | Alcon, Inc. | Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma |
US7129257B1 (en) * | 2003-12-15 | 2006-10-31 | Alcon, Inc. | Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma |
AR046890A1 (es) * | 2003-12-15 | 2005-12-28 | Alcon Inc | [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma. |
US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
US7425572B2 (en) * | 2004-12-08 | 2008-09-16 | Alcon, Inc. | Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
US20060211700A1 (en) * | 2005-03-21 | 2006-09-21 | Alcon, Inc. | (R)-8,9-dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one for controlling IOP and treating glaucoma |
WO2007149728A2 (en) * | 2006-06-20 | 2007-12-27 | Alcon Research, Ltd. | Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
US20080033183A1 (en) * | 2006-08-01 | 2008-02-07 | Alcon Manufacturing, Ltd. | Process for preparing pyranoindazole serotonergic receptor agonists |
WO2008016993A1 (en) * | 2006-08-01 | 2008-02-07 | Alcon Research, Ltd. | Intermediates and methods for serotonergic agonist synthesis |
US20080058533A1 (en) * | 2006-08-31 | 2008-03-06 | Alcon, Inc. | Pyranoindazole cyclic carbonates and methods of use |
-
2006
- 2006-08-31 TW TW095132186A patent/TW200744567A/zh unknown
- 2006-09-19 AR ARP060104098A patent/AR058055A1/es not_active Application Discontinuation
- 2006-09-19 UY UY29802A patent/UY29802A1/es not_active Application Discontinuation
- 2006-09-22 WO PCT/US2006/037148 patent/WO2007038372A1/en active Application Filing
- 2006-09-22 US US11/525,975 patent/US20070072920A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2007038372A1 (en) | 2007-04-05 |
TW200744567A (en) | 2007-12-16 |
US20070072920A1 (en) | 2007-03-29 |
AR058055A1 (es) | 2008-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY29802A1 (es) | Análogos de la feniletilamina y su uso en el tratamiento del glaucoma | |
ECSP11011067A (es) | Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos | |
UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
UY30058A1 (es) | (indazol-5-il)-piracinas y (1,3-dihidro-indol-2-on)-piracinas para el tratamiento de enfermedades y afecciones mediadas por la rho quinasa | |
PA8586001A1 (es) | Derivados de indol útiles para el tratamiento de enfermedades | |
CL2008003096A1 (es) | Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras. | |
ECSP077349A (es) | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias | |
PA8622001A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
UY31198A1 (es) | Amidas de ácidos benzoicos triazinil sustituidos, composiciones farmacéticas conteniéndolos y aplicaciones. | |
CR10041A (es) | Uso de vías inhibitorias coplementarias para el tratamiento de enfermedades oculares | |
CL2011001263A1 (es) | Compuestos derivados de pirimidinonas opcionalmente sustituidas; composicion farmaceutica que los comprende; y su uso como inhibidores de fosfodiesterasa 1 (pde1) para el tratamiento de enfermedades que involucran trastornos de la trayectoria intracelular del receptor de dopamina d1 como parkinson, alzheimer, depresion, enfermedad bipolar, hipertension, glaucoma. | |
ECSP109903A (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
UY30327A1 (es) | Nuevos compuestos ii | |
UY30470A1 (es) | Compuestos heteroarilos de cinco heteroatomos sustituidos con fenilo conteniendo nitrogeno, composiciones farmacéuticas y aplicaciones. | |
UY31982A (es) | Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas | |
PA8621901A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
UY31676A1 (es) | "derivados de 3-metil-imidiazo-[1,2-b]-piridazina" | |
ECSP088511A (es) | Agonistas del receptor del neuropeptido-2 | |
ECSP088541A (es) | [(1h-indol-5-il)-heteroariloxi]-(1-aza-biciclo[3.3.1]nonanos como ligandos colinérgicos del n-achr para el tratamiento de trastornos psicóticos y neurodegenerativos | |
PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
ECSP088905A (es) | Nuevos compuestos | |
AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
AR051472A1 (es) | Uso de inhibidores de las quinasas jun n- terminales para eltratamiento de la retinopatia glaucomatosa y enfermedades oculares | |
ECSP066770A (es) | Nuevos ésteres de quinuclidina cuaternizados | |
ECSP077323A (es) | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20180410 |